|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-05-2004
WASHINGTON (Reuters) - A next-generation leukemia pill designed to help patients not cured by the successful drug Gleevec works even better than doctors had hoped, researchers said Sunday.
NEW YORK (Reuters Health) - Sun exposure apparently has a protective effect against the development non-Hodgkin's lymphoma (NHL), a blood cancer, Australian researchers report.
LOS ANGELES (Reuters) - Nuvelo Inc.'s experimental blood clot dissolver restores function in patients with blocked catheters faster than existing therapy, the company said on Saturday.
NEW YORK (Reuters Health) - New research provides further evidence that substances in kale, spinach and other green vegetables help protect aging eyes from cataracts.
NEW YORK (Reuters Health) - As blood levels of vitamin D increase, the risk of diabetes decreases in non-Hispanic whites and Mexican Americans -- but not in blacks -- researchers have found.
WASHINGTON (Reuters) - Having sex is the high point of most women's' days, while commuting is the low point. And most women like being with their kids less than they will admit, according to a study published on Thursday.
NEW YORK (Reuters Health) - In women who've been treated for breast cancer, use of the drug tamoxifen can help prevent recurrence of the disease. Now, new research indicates that the drug works equally well in black and white women.
NEW YORK (Reuters Health) - A mobile medical information company is collecting used personal digital assistants (PDAs) to send to doctors in Africa, and outfitting the devices with the latest, up-to-date health information.
WASHINGTON (Reuters) - U.S. Food and Drug Administration Acting Commissioner Lester Crawford on Friday agreed to meet with a top Republican lawmaker about the agency's handling of safety concerns over Merck & Co Inc.'s now-withdrawn painkiller Vioxx.
WASHINGTON (Reuters Health) - Republicans' long-sought curbs on medical malpractice awards are likely to top the congressional health care agenda when lawmakers return in January, even as Democrats prepare for a clash over potential cuts to Medicaid, aides said Friday.
|
|
